Fundz

Neuro Fx, Inc. reported raising $1.89 Million in an initial SEC Form D filing, from an offering of $3.5 Million

PRIVATEApr 04, 2016$1.9M of $3.5M raised

Amount Raised

$1.89 Million

$1.89 Million sold, per SEC Form D (first sale Apr 4, 2016)

Round Type

Seed

HoustonBiotechnology

Quick answer

Theratome Bio raised $1.89 Million in a Seed round, dated April 4, 2016. Theratome Bio is based in Houston, Texas, United States.

How much did Theratome Bio raise?
Theratome Bio raised $1.89 Million in a Seed round on April 4, 2016.
What does Theratome Bio do?
Theratome Bio is a pre-clinical company developing a platform of cell-free biologics.
Where is Theratome Bio based and how big is it?
Theratome Bio is based in Houston, Texas, United States.

Source: Fundz verified event record.

Who else raised in Biotechnology around the same time

Companies in the same sectors as Theratome Bio that raised within 45 days of this round, from Fundz verified event records.

  • Medical 21 raised $10M on May 19, 2016.
  • Octeta Therapeutics, LLC raised $16M on May 19, 2016.
  • Resolys Bio raised an undisclosed amount on May 19, 2016.
  • CardioFocus, Inc. raised $8M on May 18, 2016.
  • Dexcom raised $7.2M on May 18, 2016.
  • Ascendance Biotechnology, Inc. raised $230K (Seed) on May 18, 2016.

Who to call at Theratome Bio, and when

A new round usually means Theratome Bio is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Theratome Bio raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Theratome Bio, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Theratome Bio. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Theratome Bio

Location

9128 Lakes at 610 Drive

Houston, Texas, United States

About

Theratome Bio is a pre-clinical company developing a platform of cell-free biologics. The therapeutics cover multiple areas of unmet medical need, and offer advantages over cell-based therapies, including off-the-shelf administration, convenient freezer temperature storage and delivery, and immediate bioavailability. Current therapeutic areas under development are ischemic brain injury, concussion, acute kidney injury, and increasing the shelf life of donor organs and tissues.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Theratome Bio raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Predictive Intelligence
Strategic

ML-powered predictions for Theratome Bio's next move

See what Strategic adds

Theratome Bio raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.